Pharmaceutical Research

, Volume 21, Issue 2, pp 191–200 | Cite as

Design of Freeze-Drying Processes for Pharmaceuticals: Practical Advice

Article

Abstract

Design of freeze-drying processes is often approached with a “trial and error” experimental plan or, worse yet, the protocol used in the first laboratory run is adopted without further attempts at optimization. Consequently, commercial freeze-drying processes are often neither robust nor efficient. It is our thesis that design of an “optimized” freeze-drying process is not particularly difficult for most products, as long as some simple rules based on well-accepted scientific principles are followed. It is the purpose of this review to discuss the scientific foundations of the freeze-drying process design and then to consolidate these principles into a set of guidelines for rational process design and optimization. General advice is given concerning common stability issues with proteins, but unusual and difficult stability issues are beyond the scope of this review. Control of ice nucleation and crystallization during the freezing step is discussed, and the impact of freezing on the rest of the process and final product quality is reviewed. Representative freezing protocols are presented. The significance of the collapse temperature and the thermal transition, denoted Tg`, are discussed, and procedures for the selection of the “target product temperature” for primary drying are presented. Furthermore, guidelines are given for selection of the optimal shelf temperature and chamber pressure settings required to achieve the target product temperature without thermal and/or mass transfer overload of the freeze dryer. Finally, guidelines and “rules” for optimization of secondary drying and representative secondary drying protocols are presented.

lyophilization freeze drying secondary drying formulation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

references

  1. 1.
    M. J. Pikal. Freeze-drying of proteins. Part I: process design. BioPharm 3:18-28 (1990).Google Scholar
  2. 2.
    M. J. Pikal. Freeze-drying of proteins part II: formulation selection. BioPharm 3:26-30 (1990).Google Scholar
  3. 3.
    M. J. Pikal. Freeze-Drying of Proteins. In V. H. L. Lee (ed.), Peptide and Proteins Delivery, Marcel Dekker, New York, 1998.Google Scholar
  4. 4.
    J. F. Carpenter and B. S. Chang. Lyophilization of protein pharmaceuticals. In K. Avisand and V. Wu (eds.), Biotechnology and Biopharmaceutical Manufacturing, Processing and Preservation, Intepharm Press, Buffalo Grove, IL, 1996, pp. 199-263.Google Scholar
  5. 5.
    J. M. Beals, M. J. Edwards, M. J. Pikal, and J. V. Rinella, Jr. Formulations of obesity protein, Eur. Pat. Appl. (Eli Lilly and Co., USA). EP, 1997, pp. 48Google Scholar
  6. 6.
    S. L. Nail and L. A. Gatin. Freeze-drying: principles and practice. In K. E. Avis, H. A. Lieberman, and L. Lechman (eds.), Pharmaceutical Dosage Forms: Parenteral Medications, Vol. 2, Marcel Dekker, New York, 1993, pp. 163-233.Google Scholar
  7. 7.
    F. Franks. Freeze drying: from empiricism to predictability. Cryo-Letters 11:93-110 (1990).Google Scholar
  8. 8.
    J. F. Carpenter, M. J. Pikal, B. S. Chang, and T. W. Randolph. Rational design of stable lyophilized protein formulations: some practical advice. Pharm. Res. 14:969-975 (1997).Google Scholar
  9. 9.
    A. P. Mackenzie. Basic principles of freeze-drying for pharmaceuticals. Bull. Parenter. Drug Assoc. 20:101-130 (1966).Google Scholar
  10. 10.
    M. J. Pikal and S. Shah. The collapse temperature in freeze drying: dependence on measurement methodology and rate of water removal from the glassy phase. Int. J. Pharm. 62:165-186 (1990).Google Scholar
  11. 11.
    E. Y. Shalaev and F. Franks. Changes in the physical state of model mixtures during freezing and drying: impact on product quality. Cryobio. 33:14-26 (1996).Google Scholar
  12. 12.
    P. L. Privalov. Cold denaturation of proteins. Crit. Rev. Biochem. Mol. Biol. 25:281-305 (1990).Google Scholar
  13. 13.
    Y. V. Griko, S. Y. Venyaminov, and P. L. Privalov. Heat and cold denaturation of phosphoglycerate kinase (interaction of domains). FEBS Lett. 244:276-278 (1989).Google Scholar
  14. 14.
    B. S. Chang, B. S. Kendrick, and J. F. Carpenter. Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. J. Pharm. Sci. 85:1325-1330 (1996).Google Scholar
  15. 15.
    J. F. Carpenter, S. J. Prestrelski, and T. Arakawa. Separation of freezing-and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. I. Enzyme activity and calorimetric studies. Arch. Biochem. Biophys. 303:456-464 (1993).Google Scholar
  16. 16.
    M. J. Pikal. Lyophilization. In J. Swarbrick and J. Boylan (eds.), Encyclopedia of Pharmaceutical Technology, Marcel Dekker, New York, 2002, pp. 1299-1326.Google Scholar
  17. 17.
    N. Murase and F. Franks. Salt precipitation during the freeze-concentration of phosphate buffer solutions. Biophys. Chem. 34:293-300 (1989).Google Scholar
  18. 18.
    B. A. Szkudlarek, T. J. Anchordoquy, G. A. Garcia, M. J. Pikal, J. F. Carpenter, and N. Rodriguez-Hornedo. pH changes of phosphate buffer solutions during freezing and their influence on the stability of a model protein, lactate dehydrogenase, Book of Abstracts, 211th ACS National Meeting, New Orleans, LA, 1996, pp. BIOT-138.Google Scholar
  19. 19.
    E. Shalaev, T. Johnson-Elton, L. Change, and M. J. Pikal. Thermophysical properties of pharmaceutically compatible buffers at sub-zero temperatures: implications for freeze drying. Pharm. Res. 19:195-211 (2002).Google Scholar
  20. 20.
    S. Jiang and S. L. Nail. Effect of process conditions on recovery of protein activity after freezing and freeze-drying. Eur. J. Pharm. Biopharm. 45:249-257 (1998).Google Scholar
  21. 21.
    J. A. Searles, J. F. Carpenter, and T. W. Randolph. The ice nucleation temperature determines the primary drying rate of lyophilization for samples frozen on a temperature-controlled shelf. J. Pharm. Sci. 90:860-871.Google Scholar
  22. 22.
    M. C. Heller, J. F. Carpenter, and T. W. Randolph. Protein formulation and lyophilization cycle design: prevention of damage due to freeze-concentration induced phase separation. Biotechnol. Bioeng. 63:166-174 (1999).Google Scholar
  23. 23.
    M. C. Heller, J. F. Carpenter, and T. W. Randolph. Application of a thermodynamic model to the prediction of phase separations in freeze-concentrated formulations for protein lyophilization. Arch. Biochem. Biophys. 363:191-201 (1999).Google Scholar
  24. 24.
    K-I. Izutsu, S. Yoshioka, and S. Kojima. Phase separation and crystallization of components in frozen solutions: effect of molecular compatibility between solutes. ACS Symp. Ser. 675:109-118 (1997).Google Scholar
  25. 25.
    B. Lueckel, D. Bodmer, B. Helk, and H. Leuenberger. Formulations of sugars with amino acids or mannitol-influence of concentration ratio on the properties of the freeze-concentrate and the lyophilizate. Pharm. Dev. Technol. 3:325-336 (1998).Google Scholar
  26. 26.
    N. A. Williams. Y. Lee, G. P. Polli, and T. A. Jennings. The effects of cooling rate on solid phase transitions and associated vial breakage occurring in frozen mannitol solutions. J. Parenter. Sci. Technol. 40:135-141 (1986).Google Scholar
  27. 27.
    A. Pyne, R. Surana, and R. Suryanarayanan. Crystallization of mannitol below Tg′ during freeze-drying in binary and ternary aqueous systems. Pharm. Res. 19:901-908 (2002).Google Scholar
  28. 28.
    M. J. Pikal, S. Shah, D. Senior, and J. E. Lang. Physical chemistry of freeze-drying: measurement of sublimation rates for frozen aqueous solutions by a microbalance technique. J. Pharm. Sci. 72:635-650 (1983).Google Scholar
  29. 29.
    J. A. Searles, J. F. Carpenter, and T. W. Randolph. Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine Tg′ in pharmaceutical lyophilization. J. Pharm. Sci. 90: 872-887.Google Scholar
  30. 30.
    M. J. Pikal, S. Shah, M. L. Roy, and R. Putman. The secondary drying stage of freeze drying: drying kinetics as a function of temperature and chamber pressure. Int. J. Pharm. 60:203-217 (1990).Google Scholar
  31. 31.
    R. P. Bhattacharyya and T. R. Sosnick. Viscosity dependence of the folding kinetics of a dimeric and monomeric coiled coil. Biochem. 38:2601-2609 (1999).Google Scholar
  32. 32.
    H. A. Kramers. Brownian motion in a field of force and the diffusion model of chemical reactions. Physica 7:284-304 (1940).Google Scholar
  33. 33.
    X. Ma, D. Q. Wang, R. Bouffard, and A. MacKenzie. Characterization of murine monoclonal antibody to tumor necrosis factor (TNF-MAb) formulation for freeze-drying cycle development. Pharm. Res. 18:196-202 (2001).Google Scholar
  34. 34.
    M. J. Pikal. Mechanisms of protein stabilization during freeze-drying and storage: the relative importance of thermodynamic stabilization and glassy state relaxation dynamics. Drugs Pharm. Sci. 96:161-198 (1999).Google Scholar
  35. 35.
    M. J. Pikal and J. E. Lang. Rubber closures as a source of haze in freeze dried parenterals: test methodology for closure evaluation. J. Parenter. Drug Assoc. 32:162-173 (1978).Google Scholar
  36. 36.
    M. J. Pikal, M. L. Roy, and S. Shah. Mass and heat transfer in vial freeze-drying of pharmaceuticals: role of the vial. J. Pharm. Sci. 73:1224-1237 (1984).Google Scholar
  37. 37.
    N. Milton, M. J. Pikal, M. L. Roy, and S. L. Nail. Evaluation of manometric temperature measurement as a method of monitoring product temperature during lyophilization. PDA J. Pharm. Sci. Technol. 51:7-16 (1997).Google Scholar
  38. 38.
    X. C. Tang, S. L. Nail, and M. J. Pikal. Mass transfer in freeze drying: measurement of dry layer resistance by a non-steady state method (the MTM procedure). 1999 AAPS Anual Meeting, New Orleans, Louisiana, 1999.Google Scholar
  39. 39.
    X. C. Tang, S. L. Nail, and M. J. Pikal. Freeze drying process optimization by manometric temperature measurement, 2001 AAPS Annual Meeting, Denver, Colorado, 2001.Google Scholar
  40. 40.
    M. J. Pikal. Use of laboratory data in freeze drying process design: heat and mass transfer coefficients and the computer simulation of freeze drying. J. Parenter. Sci. Technol. 39:115-139 (1985).Google Scholar
  41. 41.
    M. L. Roy and M. J. Pikal. Process control in freeze drying: determination of the end point of sublimation drying by an electronic moisture sensor. J. Parenter. Sci. Technol. 43:60-66 (1989).Google Scholar
  42. 42.
    M. J. Pikal, K. M. Dellerman, and M. L. Roy. Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone. Develop. Bio. Standard. 74:21-38 (1991).Google Scholar
  43. 43.
    M. J. Hageman. The role of moisture in protein stability. Drug Dev. Ind. Pharm. 14:2047-2070 (1988).Google Scholar
  44. 44.
    M. S. Kamat, R. A. Lodder, and P. P. DeLuca. Near-infrared spectroscopic determination of residual moisture in lyophilized sucrose through intact glass vials. Pharm. Res. 6:961-965 (1989).Google Scholar
  45. 45.
    I. Presser, N. Denkinger, H. Hormann, and G. Winter. New methods in monitering of freeze-drying: near-infrared spectroscopy determination of residue moiture during freeze-drying, 2002 Protein Stability Conference, Breckenridge, Colorado, 2002.Google Scholar
  46. 46.
    E. Maltini. Estimation of the viscosities of the frozen sucrose-water system from glass transition temperatures. Ita. J. Food Sci. 4:371-377 (1993).Google Scholar

Copyright information

© Plenum Publishing Corporation 2004

Authors and Affiliations

  1. 1.School of PharmacyUniversity of ConnecticutStorrs

Personalised recommendations